clinical trial · NCT00140972
A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)
Organon and Co·phase4·completed·n = 160
OsteoarthritisMK0663; etoricoxib / Duration of Treatment:4 WeeksComparator: diclofenac sodium tablet 75 mg / Duration of Treatment:4 Weeks
brief summary
A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip
started
Dec 3, 2004
primary completion
Jun 27, 2005
completion
Jun 27, 2005
last updated
Aug 15, 2024
official title
A Multicenter, Randomized, Parallel-group, 4-Week, Double-Blind and Active Comparator-Controlled Study to Assess Efficacy, Safety, and Tolerability of Etoricoxib 60 mg Once Daily Versus Diclofenac Sodium 75 mg Twice Daily in the Treatment of Chinese Patients With Osteoarthritis of the Knee or Hip
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol